This price will be extremely cheap if we get the expected positive results. geta could see 100 a share in the blink of an eye with a melonoma drug approval and major interest from the big pharmas to buy them out . This will be tremendously huge there is no better way to say it
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.